Amgen shares remain Market Perform rated, Leerink raises target …

Nov 27, 2024 · On Wednesday, Leerink Partners adjusted its price target for Amgen (NASDAQ: AMGN) stock, lowering it from $352 to $305, while maintaining a Market Perform rating.The …

CouponFollow Extension

$352
OFF

Amgen Shares Remain Market Perform Rated, Leerink Raises Target …

2 weeks from now

Nov 27, 2024 · On Wednesday, Leerink Partners adjusted its price target for Amgen (NASDAQ: AMGN) stock, lowering it from $352 to $305, while maintaining a Market Perform rating.The …

investing.com

6%
OFF

Amgen Climbs After Being Upgraded To 'Outperform' At Leerink

2 weeks from now

Oct 11, 2023 · Shares of Amgen climbed 2.6% shortly after the upgrade was published. Leerink’s $318 price target implies an upside of 17% from yesterday’s close. Amgen climbs after being …

investing.com

$305
OFF

Amgen Inc.: Target Price Consensus And Analysts …

2 weeks from now

Jan 13, 2025 · Leerink Partners Adjusts Price Target on Amgen to $305 From $352, Maintains Market Perform Rating Nov. 27: MT Redburn Atlantic Adjusts Price Target on Amgen to $195 …

marketscreener.com

3%
OFF

Amgen Rises After Leerink Partners Upgrades On Potential

2 weeks from now

Oct 11, 2023 · ** Shares of Amgen NASDAQ:AMGN rise 3% to $279.46 ** Brokerage Leerink Partners upgrades to "outperform" from "market perform," raises PT to $318 from $267** The …

tradingview.com

$256
OFF

SVB Leerink Maintains Market Perform On Amgen, Raises Price …

2 weeks from now

Dec 22, 2022 · SVB Leerink analyst David Risinger maintains Amgen (NASDAQ:AMGN) with a Market Perform and raises the price target from $256 to $282.

benzinga.com

$267
OFF

Leerink Partners Upgrades Amgen To Outperform, Raises Price …

2 weeks from now

Oct 11, 2023 · Leerink Partners analyst David Risinger upgrades Amgen (NASDAQ:AMGN) from Market Perform to Outperform and raises the price target from $267 to $318.

sahmcapital.com

$383.00
OFF

Amgen’s Growth Potential Affirmed: Buy Rating With Increased …

2 weeks from now

Oct 21, 2024 · TD Cowen analyst Yaron Werber maintained a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $383.00.. Yaron Werber has given his Buy …

businessinsider.com

$302.00
OFF

Amgen (NASDAQ:AMGN) Price Target Lowered To $302.00 At …

2 weeks from now

Dec 1, 2024 · Amgen (NASDAQ:AMGN – Free Report) had its target price lowered by Leerink Partners from $349.00 to $302.00 in a research report sent to investors on Wednesday …

slatersentinel.com

$318
OFF

Amgen Downgraded To Market Perform From Outperform At …

2 weeks from now

Leerink analyst David Risinger downgraded Amgen (AMGN) to Market Perform from Outperform with a price target of $318, down from $324. The firm says that Amgen’s inv... Stocks. Top …

tipranks.com

07%
OFF

Amgen: Multiple Strengths, But The Valuation Is A Concern

2 weeks from now

11 hours ago · Despite Amgen's rising share price, the dividend yield is still above its 5-year average of 3.07%. The forward yield is now about 3.1% after the recent price gain after …

seekingalpha.com

2%
OFF

Amgen Down After Leerink Partners Downgrades Stock On

2 weeks from now

Feb 7, 2024 · ** Amgen AMGN shares fall ~2% to $309.87 premarket ** Brokerage Leerink Partners downgrades stock to "Market Perform" from "Outperform", raises PT to $324 from …

tradingview.com

$314.00
OFF

Amgen (AMGN) Stock Forecast And Price Target 2025 - MarketBeat

2 weeks from now

4 days ago · According to the 27 analysts' twelve-month price targets for Amgen, the average price target is $314.00. The highest price target for AMGN is $405.00, while the lowest price …

marketbeat.com

FAQs about Amgen shares remain Market Perform rated, Leerink raises target … Coupon?

Why did Leerink downgrade Amgen (AMGN)?

Leerink Partners downgraded Amgen ( NASDAQ: AMGN) to Market Perform from Outperform, citing overly high expectations from the company's R&D program related to obesity drugs. Analyst David Risinger argues that Amgen's ( AMGN) obesity prospects have risen significantly since Leerink's October upgrade, leading to a sizable P/E expansion. ...

What is the average price target for Amgen?

According to the 27 analysts' twelve-month price targets for Amgen, the average price target is $314.00. The highest price target for AMGN is $405.00, while the lowest price target for AMGN is $195.00. The average price target represents a forecasted upside of 8.70% from the current price of $288.87. ...

Is Amgen (Amgen) a good stock to buy?

Overall, Risinger’s Hold rating reflects a balanced view of Amgen’s current position and its potential for growth against the backdrop of certain uncertainties and pending milestones. In another report released on February 22, Bank of America Securities also maintained a Hold rating on the stock with a $315.00 price target. ...

Why has Yaron Werber rated Amgen (Amgen) a buy?

Yaron Werber has given his Buy rating due to a combination of factors affecting Amgen’s stock. Primarily, the increase in the price target to $383 reflects a positive outlook, driven by a slight adjustment in the valuation multiple applied to future earnings. ...

How has Amgen's share price changed over the past 12 months?

The share price rose about 6% in response and has been trending upward since the start of the year on investor optimism. The share price has gained ~17.8% year-to-date ("YTD") but lost ~4.7% in the past twelve months. Amgen's revenue has gained yearly from 2015 to 2024, except for slight declines in 2017 and 2019. ...

Is Amgen (Amgen) overvalued?

The two-model average is ~$299.37, indicating that Amgen is overvalued at the current price. However, Wall Street analysts are somewhat less bullish, with an average price target of $313.66, 2.5% higher than the current value and more than our two-model average. ...